1. Metabolism and excretion studies in mouse after single and multiple oral doses of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin;Black;Drug Metab. Dispos.,1998
2. Metabolism and excretion of atorvastatin in rats and dogs;Black;Drug Metab. Dispos.,1999
3. Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis;Butler;Investig. Ophthalmol. Vis. Sci.,1996
4. Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis;Caspi;Int. Rev. Immunol.,2002
5. Multiple-dose pharmacokinetics, pharmacodynamics, and safety and atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects;Cilla;Clin. Pharmacol. Ther.,1996